Skip to Content

Notice

Memorandum of Understanding Between the Food and Drug Administration, Duke University and Duke University Health System, Inc.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA, Duke University (DU) and Duke University Health System, Inc. (DUHS). The purpose of the MOU is to establish the terms of collaboration between FDA, DU and DUHS to support shared interests and will begin with an initiative entitled: The FDA, DU and DUMC Elective Program.

DATES:

The agreement became effective September 18, 2006.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Nancy L. Pluhowski, Center for Devices and Radiological Health (HFZ-1), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-827-2890.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: January 25, 2007.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature Start Printed Page 5063

Start Printed Page 5064

Start Printed Page 5065

Start Printed Page 5066

Start Printed Page 5067

Start Printed Page 5068

End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 07-454 Filed 2-1-07; 8:45 am]

BILLING CODE 4160-01-C